FDA Creates CMC Pilots To Put Quality Assessment Principles Into Practice
This article was originally published in The Pink Sheet Daily
Executive Summary
NDA and ANDA pilot programs will help transform the way CMC information is submitted and reviewed by FDA. Office of Generic Drugs' white paper on "question-based review" follows the introduction of an NDA pilot program in mid-July.